FORMULATION AND EVALUATION OF SUSTAINED-RELEASE FLOATING MATRIX TABLETS OF VALGANCICLOVIR HYDROCHLORIDE

YASHAVANTH G.; PRAKASH GOUDANAVAR; MALLAMMA T.; SANTHOSH FATTEPUR

doi:10.22159/ijap.2024v16i2.49521

Authors

YASHAVANTH G. Department of Pharmaceutics, Sri Adichunchanagiri College of Pharmacy, BG Nagar, Karnataka 571488, India https://orcid.org/0009-0006-5256-5718
PRAKASH GOUDANAVAR Department of Pharmaceutics, Sri Adichunchanagiri College of Pharmacy, BG Nagar, Karnataka 571488, India https://orcid.org/0000-0002-2511-8828
MALLAMMA T. Department of Pharmaceutics, Sri Adichunchanagiri College of Pharmacy, BG Nagar, Karnataka 571488, India https://orcid.org/0009-0000-3709-0247
SANTHOSH FATTEPUR Department of Pharmaceutics, Sri Adichunchanagiri College of Pharmacy, BG Nagar, Karnataka 571488, India

DOI:

https://doi.org/10.22159/ijap.2024v16i2.49521

Keywords:

Gastroprotective, Valganciclovir hydrochloride, AIDS, DOE

Abstract

Objective: The present study aimed to formulate and evaluate the formulated sustained-release floating matrix tablets of valganciclovir hydrochloride to produce a stable and bioavailable dosage form.

Methods: The tablets were prepared using hydrophilic and hydrophobic polymers such as ethyl cellulose, Hydroxy-propyl methylcellulose (HPMC), and Povidone. The formulations were subjected to evaluation characteristics such as drug content, hardness, friability, floating lag time, total floating time, and In vitro drug dissolution studies.

Results: The formulation composition and method of manufacturing are novel for this particular active moiety and robustness was assessed using a central composite design. All the formulation trials exhibited more than 90% of drug release in 12 h duration, with a floating lag time of more than 11 h, and drug content was found more than 90% across the batches. The hardness and friability profiles were found to be uniform across the batches. The preliminary evaluation confirms the received drug is pure and FTIR results show that the drug and excipients are compatible. The hardness and friability profiles were found consistent across the batches. All the formulation trials of central composite design have shown more than 90% of drug release in 12 h duration, with a floating lag time of more than 11 h, and drug content was found more than 90% across the batches.

Conclusion: The formulated valganciclovir hydrochloride sustained release floating matrix tablets showed an increased GRT with a sustained release for 12 h, thereby allowing a better window for absorption and consequently improving the drug's therapeutic effect.

Downloads

Download data is not yet available.

References

Fakhreddine AY, Frenette CT, Konijeti GG. A practical review of cytomegalovirus in gastroenterology and hepatology. Gastroenterol Res Pract. 2019. doi: 10.1155/2019/6156581, PMID 30984257.

Bachynsky MO, Nutley NJ, Montclair NJ, Hoffman-La Roche Inc. Pharmaceutical dosage forms comprising valganciclovir hydrochloride. Com. United States Patent US; 2014. Available form: https//storage.googleapis:109/e2/5f/d7/41e5cbf33135d3/US8889109.pdf. [Last accessed on 18 Nov 2014]

Patel SS, Ray S, Thakur RS. Formualtion and evaluation of floating drug delivery system containing clarithromycin for Helicobacter pylori. Acta Pol Pharm. 2006 Jan-Feb;63(1):53-61. PMID 17515330.

Sheela NBS, Damodharan N, Madhukar BS, Surekha T. Formulation and evaluation of clarithromycin gastro retentive form. Int J Pharm Pharm Sci. 2013 Mar 5;30:174-6.

Teaima MH, Abdelmonem R, Saady M, EL-Nabarawi MA, Shoman NA. Comprehensive overview on recent updates of gastroretentive raft-forming system S. Int J App Pharm. 2022 May 7:40-8. doi: 10.22159/ijap.2022v14i3.44098.

Rajeswari S, Kudamala S, Murthy KVR. Development, formulation and evaluation of a bilayer gastric retentive floating tablets of ranitidine HCl and clarithromycin using natural polymers. Int J Pharm Pharm Sci. 2017 Jul 22;9(9):164. doi: 10.22159/ijpps.2017v9i9.20290.

Yashavanth G, Goudanavar P, Mallamma T. Floating drug delivery system: a review. Int J Adv Res. 2022 Nov 30;10(11):161-7. doi: 10.21474/IJAR01/15653.

More S, Gavali K, Doke O, Kasgawade P. Gastroretentive drug delivery system. J Drug Delivery Ther. 2018;8(4):24-5. doi: 10.22270/jddt.v8i4.1788.

Sabale V, Sakarkar S, Pund S, Sabale P. Formulation and evaluation of floating dosage forms: an overview. Syst Rev Pharm. 2010;1(1):33. doi: 10.4103/0975-8453.59510.

Libretexts. Physical and thermal analysis; 2022. Available from: https://chem.libretexts.org/Bookshelves/Analytical_Chemistry/Physical_Methods_in_Chemistry_and_Nano_Science_(Barron)/02%3A_Physical_and_Thermal_Analysis.

TR, SP, AD, Y SK. Formulation and evaluation of valacyclovir hydrochloride effervescent floating tablets. Int J Adv Pharm Biotechnol. 2021 Mar 1;7(1):30-6. doi: 10.38111/ijapb.20210701006.

Harsolekar M, Ansari M, Supe S, Singh K. Formulation development and evaluation of therapeutic contact lens loaded with ganciclovir. Int Ophthalmol. 2023;43(7):2225-36. doi: 10.1007/s10792-022-02618-6, PMID 36593425.

Taghizadeh Davoudi E, Ibrahim Noordin M, Kadivar A, Kamalidehghan B, Farjam AS, Akbari Javar H. Preparation and characterization of a gastric floating dosage form of capecitabine. BioMed Res Int. 2013 Jan 1;2013:495319. doi: 10.1155/2013/495319, PMID 24288681.

Taghizadeh Davoudi E, Ibrahim Noordin M, Kadivar A, Kamalidehghan B, Farjam AS, Akbari Javar H. Preparation and characterization of a gastric floating dosage form of capecitabine. BioMed Res Int. 2013;2013:495319. doi: 10.1155/2013/495319, PMID 24288681.

Sundaram DT, Kamat AG, Prabahar KJ, Gupta PB, Venkateswara Rao B, Paul Douglas S. An alternative approach to isoganciclovir: a prominent impurity in the antiviral drug ganciclovir. Sci Pharm. 2015;83(2):233-41. doi: 10.3797/scipharm.1409-15, PMID 26839813.

Sundaram DT, Kamat AG, Prabahar KJ, Gupta PB, Venkateswara Rao B, Paul Douglas S. An alternative approach to isoganciclovir: a prominent impurity in the antiviral drug ganciclovir. Sci Pharm. 2015;83(2):233-41. doi: 10.3797/scipharm.1409-15, PMID 26839813, PMCID PMC4727779.

Karthik K, Jose GBC, Sowmya HG. A review on analytical method development and validation of valganciclovir hydrochloride. World J Pharm Res. 2019 Sep 8;11:219-25. doi: 10.20959/wjpr201911-15772.

Radha GV, Sastri KT, Manaswin N, Likhitha B. Formulation development and evaluation of sustained release gastroretentive tablet of emtricitabine. Int J App Pharm. 2019 Aug 6:236-40. doi: 10.22159/ijap.2019v11i5.34840.

Gharti K, Thapa P, Budhathoki U, Bhargava A. Formulation and in vitro evaluation of floating tablets of hydroxypropyl methylcellulose and polyethylene oxide using ranitidine hydrochloride as a model drug. J Young Pharm. 2012 Oct;4(4):201-8. doi: 10.4103/0975-1483.104363, PMID 23493037, PMCID PMC3573371.